黑人男性晚期前列腺癌的系统疗法的差异:我们站在哪里?
Jun Gong1, Daniel M Kim1, Amanda M De Hoedt2
1Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
概括
前列腺癌治疗结果的种族差异在黑人患有转移性疾病的男性中正在缩小. 有证据表明,当获得护理公平时,全身疗法具有类似或更好的结果.
科学领域:
- 在瘤学瘤学.
- 健康差距 研究 研究 研究 研究
- 癌症治疗结果的结果
背景情况:
- 前列腺癌不成比例地影响黑人男性,有记录的差异影响生存率.
- 从历史上看,患有前列腺癌的黑人男性与白人男性相比,面临着更差的结果.
- 多层次的差异对这些生存差异作出了重大贡献.
研究的目的:
- 审查黑人男性转移性前列腺癌全身治疗结果的种族差异趋势.
- 为了比较黑人和白人男性接受高级前列腺癌全身治疗的结果.
- 调查公平获得医疗保健对治疗结果的影响.
主要方法:
- 对现实世界注册表数据的审查.
- 对未来临床试验的分析.
- 专注于标准化医疗保健提供和随访的研究.
主要成果:
- 越来越多的证据表明,黑人男性在转移性前列腺癌中与白人男性相比,在全身疗法中可能达到类似或更好的结果.
- 前性研究和临床试验证实了这些发现,特别是在标准化护理的环境中.
- 公平获得医疗保健和随访似乎有助于缓解结果差异.
结论:
- 非生物因素是晚期前列腺癌种族差异的关键驱动因素.
- 消除医疗保健获取和提供障碍至关重要.
- 增加对临床试验的参与是克服黑人男性系统治疗结果差异的关键.
相关概念视频
Disorders of the Male Reproductive System
431
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
431
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


